- Some generic drug firms are under modest pressure in apparent response to a speech delivered by U.S. Department of Justice antitrust division chief Makan Delrahim earlier today at George Mason University's law school. He said the DOJ may sue generic drug companies to recover damages over alleged price-fixing, adding that if taxpayers were overcharged due to collusion to raise prices, then seeking remedies may be appropriate.
- The antitrust division and state AGs are involved in an ongoing investigation into alleged price-fixing by generic drugmakers.
- Source: Bloomberg
- Selected tickers: (AMPH -0.4%)(ANIP +0.2%)(ACRS +1.9%)(AKRX -0.4%)(COLL +13.3%)(RDY +1.5%)(EGRX -0.3%)(IPXL -1.9%)(LCI -0.2%)(MYL -0.3%)(PRGO +0.1%)(TLGT -1.1%)(TEVA -1.4%)(ENDP -4.8%)(MNTA +6.4%)
U.S. Justice Department may seek damages from generic drugmakers for price-fixing
Recommended For You
About AMPH Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
AMPH | - | - |
Amphastar Pharmaceuticals, Inc. |